Merck & Co., Inc. is a global research-driven pharmaceutical products company. Committed to bringing out the best in medicine
Contact usWorldwide
HomeAbout MerckProductsNewsroomInvestor InformationCareersResearchLicensingThe Merck Manuals

The Merck Manual--Second Home Edition logo
 
click here to go to the Index click here to go to the Table of Contents click here to go to the search page click here for purchasing information
Chapter 63. Bone Tumors
Topics: Introduction | Noncancerous Bone Tumors | Primary Cancerous Bone Tumors | Metastatic Bone Tumors
 
green line

Metastatic Bone Tumors

Metastatic bone tumors are cancers that have spread to the bone from their original site elsewhere in the body (see Section 15, Chapter 180). Cancers most likely to spread to the bone include those of the breast, lung, prostate gland, kidney, and thyroid gland. Cancer may spread to any bone but usually does not spread beyond the elbow and knee.

A person who has or has had cancer and develops bone pain or swelling usually is examined for metastatic bone tumors. Bone scans using radioactive tracers and x-rays can help locate these tumors. Occasionally, a metastatic bone tumor produces symptoms before the original cancer has been detected. Symptoms may consist of pain or a fracture where the tumor has weakened the bone (a pathologic fracture). In these situations, a biopsy usually gives clues as to the location of the original cancer, because the type of tissue from which the cancer derived can often be recognized under the microscope.

Treatment depends on the type of cancer that has spread to the bone. Some types respond to chemotherapy, some to radiation therapy, some to both, and some to neither. Surgery to stabilize the bone can sometimes prevent fractures. When the original (primary) cancer has been removed and only a single metastasis in the bone remains, surgical removal combined with radiation therapy, chemotherapy, or both is sometimes curative.

Site MapPrivacy PolicyTerms of UseCopyright 1995-2004 Merck & Co., Inc.